EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,469	523	1,088	119	415	100
Market Cap Growth	133.64%	-51.95%	811.96%	-71.25%	316.71%	-40.59%
Enterprise Value	1,288	292	958	8	334	125
Last Close Price	17.74	7.45	23.11	3.50	12.24	6.58
PS Ratio	28.75	12.08	23.64	2.88	11.23	2.89
PB Ratio	6.17	1.55	4.09	1.24	2.25	5.37
P/TBV Ratio	7.34	1.55	4.09	1.24	2.57	-
P/OCF Ratio	-	-	580.20	-	-	-
EV/Sales Ratio	30.42	6.75	20.82	0.21	9.05	3.62
Debt / Equity Ratio	0.12	0.07	0.02	0.48	0.21	2.22
Asset Turnover	0.15	0.11	0.17	0.19	0.21	0.42
Inventory Turnover	82.88	43.12	20.06	17.83	8.06	6.22
Quick Ratio	6.81	7.58	5.25	4.64	9.72	3.65
Current Ratio	7.18	7.82	5.45	5.00	10.05	4.24
Return on Equity (ROE)	-98.23%	-43.42%	-39.04%	-72.84%	-57.58%	-337.87%
Return on Assets (ROA)	-49.38%	-23.57%	-17.52%	-22.24%	-19.46%	-28.30%
Return on Capital (ROIC)	-58.65%	-28.88%	-22.64%	-26.94%	-24.40%	-39.32%
Return on Capital Employed (ROCE)	-98.50%	-39.50%	-25.70%	-54.10%	-23.10%	-48.50%
Earnings Yield	-14.01%	-25.04%	-6.51%	-85.72%	-14.08%	-45.60%
FCF Yield	-14.54%	-24.92%	-0.15%	-56.29%	-12.11%	-14.86%
Buyback Yield / Dilution	-35.36%	-44.71%	-4.25%	-29.76%	-124.04%	-23.06%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q